Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today presented its financial calendar for 2017 and has joined the Pass French Tech program.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2017/02/QGC_PR_Agenda-2017_20170220_EN.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
